安心交易
不成功退款,无后顾之忧,风险服务升级。Cancers (ISSN 2072-6694; CODEN: CANCCT) is an open access journal of oncology published monthly online by MDPI.Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed electronic files or software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds we accept studies showing meaningful but negative results. While there are many journals that focus on cancer studies, none of them actively accepts negative results. As a result, most negative data end up not being in the public domain even if the data were meaningfully negative and the study well designed. By accepting those negative results, our journal encourages scientists to share those data so that they would not need to repeat the experiments that somebody else has already done. Open Access - free for readers, with publishing fees paid by authors or their institutions. Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 29 days after submission; acceptance to publication is undertaken in 6 days (median values for papers published in this journal in 2016). For Cancers (ISSN 2072-6694), authors are asked to pay a fee of 850 CHF (Swiss Francs) per processed paper, but only if the article is accepted for publication in this journal after peer-review and possible revision of the manuscript. Note that many national and private research funding organizations and universities explicitly cover such fees for articles originated in funded research projects. Discounts are available for authors from institutes that participate with MDPI''s membership program. In addition to Swiss Francs (CHF), we also accept payment of the fees in Euros (EUR), US Dollars (USD) or Chinese Yuan (CNY). Current exchange rates published at XE plus 5% exchange commission apply.
癌症(ISSN 2072 - 6694;CODEN: CANCCT)是一份开放获取的肿瘤杂志,每月由MDPI在线出版。《癌症》(ISSN 2072-6694)是一本国际性的、同行评审的肿瘤学开放获取期刊。它发表评论、定期研究论文和简短的交流。我们的目标是鼓励科学家尽可能详细地发表他们的实验和理论结果。这篇论文的篇幅没有限制。必须提供完整的实验细节,以便重现结果。此外,这本杂志还有一些独特的特点:特别欢迎有关研究建议和研究想法的手稿有关计算和实验程序的全部细节的电子文件或软件,如不能正常发表,可作为补充材料存放我们也接受与更广泛的读者交流有关公共资金资助的研究项目的手稿我们接受有意义但结果消极的研究。虽然有很多期刊关注癌症研究,但没有一本积极接受负面结果。结果,大多数负面数据最终都不在公共领域,即使这些数据是有意义的负面数据,而且研究设计得很好。通过接受这些消极的结果,我们的杂志鼓励科学家们分享这些数据,这样他们就不需要重复别人已经做过的实验。开放存取-免费为读者,出版费用由作者或他们的机构支付。快速出版:稿件经过同行评审,并在投稿后约29天向作者提供第一个决定;发表验收时间为6天(2016年发表论文中位数)。对于癌症(ISSN 2072-6694),作者被要求为每一篇处理过的论文支付850瑞士法郎(瑞士法郎)的费用,但前提是这篇文章在同行评审和可能的手稿修改后被接受发表在本刊上。请注意,许多国家和私人研究资助机构和大学都明确为源自资助研究项目的文章支付此类费用。参加MDPI会员计划的机构的作者可享受折扣。除瑞士法郎(CHF)外,我们还接受欧元(EUR)、美元(USD)或人民币(CNY)的费用支付。现行汇率按XE + 5%的汇率计算。
安心交易
不成功退款,无后顾之忧,风险服务升级。合规备案认证机构
资质许可齐全,合规经营,用户权益有保障。正刊保障
刊物在国家新闻出版署网可查,抵制假刊、增刊。对公账户资金监管
交易均通过对公账户,资金安全有保障。国内期刊
中文文章服务首选国际期刊
英文文章服务首选国际会议
会议文章服务首选评职加分
评职称文章服务首选812751拥有老客户
918539评职称指导
63352国际出版服务
819867开具合同